Shawn O’Connor serves as the Chief Executive Officer at Simulations Plus, Inc., a leading provider of modeling and simulation software for pharmaceutical research and development. With a robust background in the life sciences industry, O’Connor has been instrumental in steering the company towards growth and innovation. Prior to joining Simulations Plus, he held various leadership positions, including President and CEO of DPT Laboratories, a contract development and manufacturing organization, where he significantly expanded the company's capabilities and market reach. At Simulations Plus, O’Connor has been pivotal in driving the company’s strategic vision and operational excellence. Under his leadership, the company has seen substantial growth in its client base and revenue, largely attributed to his focus on enhancing product offerings and expanding into new markets. His strategic initiatives have included the development of cutting-edge software solutions that assist pharmaceutical companies in optimizing drug development processes, thereby reducing time and costs. O’Connor's commitment to fostering a culture of innovation and collaboration has positioned Simulations Plus as a frontrunner in the industry. In addition to his professional achievements, Shawn O’Connor is known for his active involvement in industry associations and his contributions to thought leadership in the pharmaceutical sector. He frequently speaks at conferences and contributes to publications, sharing insights on the future of drug development and the role of technology in advancing healthcare. His leadership at Simulations Plus not only reflects his deep industry knowledge but also his dedication to improving the efficiency and effectiveness of drug development worldwide.